36results about How to "Good anti-hepatic fibrosis effect" patented technology

The Chinese medicine composition for treating liver fibrillation and liver cirrhosis has active components prepared from red sage, astragalus root, other medicine(s) with function of promoting blood circulation to disperse blood clots, spleen invigorating medicine(s) and vital energy regulating medicine(s). The active comprises are matched with pharmaceutically acceptable carrier or excipient to prepare various preparation forms. The Chinese medicine composition has high practical curative rate in treating liver fibrillation, no recurrence and no toxic side effect.

The invention involves the use of the total flavonoids of the fields to prepare for the treatment of drugs for the treatment of liver fibrosis.Total yellow total flavonoids are an active ingredient extracted from Hypericum Japonicum Thunb.).The present invention further provides a pharmaceutical composition for the treatment of liver fibrosis. The drug composition includes an effective treatment dose as an active ingredients as a field -based yellow flavonoids, and a pharmaceutical acceptable carrier.The present invention shows that through animal experiments, the total flavonoids of the fields have a good anti -liver fibrosis, and have no poisonous side effects. They can be used to prepare drugs for the treatment of liver fibrosis and are used for clinical liver fibrosis.

The invention relates to an anti-hepatic fibrosis drug composite. The anti-hepatic fibrosis drug composite is characterized by comprising the following crude drugs in parts by weight: 5-15 parts of artemisia anomala, 10-20 parts of geranium wilfordii, 1-5 parts of leeches and 1-5 parts of Zhechong. The anti-hepatic fibrosis drug composite disclosed by the invention can be used for preparing the artemisia anomala, the geranium wilfordii, the leeches and the zhechong into a compound according to a traditional Chinese medicine theory, achieves the purpose of anti-hepatic fibrosis through the synergistic action of the drugs on the aspects of anti-inflammation, anti-necrosis, hepatic cells protection, and the like and has the advantages of low price and easiness for popularization.

The invention relates to a method for separating and extracting C15H18O5 from Cichorium glandulosum Boiss.et Hout and use of C15H18O5 the English name of which is 11B, 13-Dihydrolacurin. The method is characterized by comprising the following steps: soaking the root of Cichorium glandulosum Boiss.et Hout by ethanol; collecting the percolate by a percolation method; obtaining a thick extract by a reduced pressure distillation device; passing the extract through a silicagel column, an octadecylsilyl column and a Sephadex LH-20 column; eluting; and drying the eluant by the reduced pressure distillation device to obtain dry powder which is the monomer C15H18O5, the English name of which is 11B, 13-Dihydrolacurin. The compound has the effect of preventing anti-hepatic fibrosis, namely, the compound inhibits activating and proliferating effect of hepatic stellate cells, so that the C15H18O5 with the English name of 11B, 13-Dihydrolacurin can be used as a lead compound for preventing anti-hepatic fibrosis.